Metalloproteinases and plasminogen activators in vesset remodeling

被引:38
作者
Bobik, A [1 ]
Tkachuk, V [1 ]
机构
[1] Baker Heart Res Inst, Cell Biol Lab, Melbourne, Vic 8008, Australia
关键词
D O I
10.1007/s11906-003-0054-5
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
Remodeling of blood vessels underlies the pathogenesis of major cardiovascular disorders, including atherosclerosis, restenosis, and hypertension. Because remodeling of arteries is highly dependent on degradation of the extracellular matrix, which enables cells to migrate and proliferate, there is intense interest in the regulation and the roles of matrix metalloproteinases (MMPs) and the plasminogen activator-plasmin (PA-P) systems in vessel remodeling. Factors that promote vessel remodeling have been shown to be important in upregulating the activities of both proteolytic systems and include chronic changes in hemodynamics, vessel injury, cytokines involved in inflammation, and elevations in reactive oxygen species. The two proteolytic systems utilize common transcription factors to active their respective genes and are frequently coexpressed in remodeling and atherosclerotic arteries. In this review, we discuss the effects of activating the MMP and PA-P systems on processes involved in vascular remodeling, factors regulating their expression and activation, their roles in restenosis, and the development and progression of atherosclerosis, as well as the ability of currently available inhibitors to prevent unfavorable remodeling and atherosclerosis.
引用
收藏
页码:466 / 472
页数:7
相关论文
共 53 条
[1]  
Amorino GP, 1998, AM J PATHOL, V152, P199
[2]   Inhibition of transcription factor NF-κB reduces matrix metalloproteinase-1,-3 and-9 production by vascular smooth muscle cells [J].
Bond, M ;
Chase, AJ ;
Baker, AH ;
Newby, AC .
CARDIOVASCULAR RESEARCH, 2001, 50 (03) :556-565
[3]   Tissue inhibitors of metalloproteinases: evolution, structure and function [J].
Brew, K ;
Dinakarpandian, D ;
Nagase, H .
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEIN STRUCTURE AND MOLECULAR ENZYMOLOGY, 2000, 1477 (1-2) :267-283
[4]   IDENTIFICATION OF 92-KD GELATINASE IN HUMAN CORONARY ATHEROSCLEROTIC LESIONS - ASSOCIATION OF ACTIVE ENZYME-SYNTHESIS WITH UNSTABLE ANGINA [J].
BROWN, DL ;
HIBBS, MS ;
KEARNEY, M ;
LOUSHIN, C ;
ISNER, JM .
CIRCULATION, 1995, 91 (08) :2125-2131
[5]   Urokinase-generated plasmin activates matrix metalloproteinases during aneurysm formation [J].
Carmeliet, P ;
Moons, L ;
Lijnen, HR ;
Baes, M ;
Lemaitre, V ;
Tipping, P ;
Drew, A ;
Eeckhout, Y ;
Shapiro, S ;
Lupu, F ;
Collen, D .
NATURE GENETICS, 1997, 17 (04) :439-444
[6]   Role of nuclear factor-κB activation in metalloproteinase-1,-3, and-9 secretion by human macrophages in vitro and rabbit foam cells produced in vivo [J].
Chase, AJ ;
Bond, M ;
Crook, MF ;
Newby, AC .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2002, 22 (05) :765-771
[7]   Transmural pressure induces matrix-degrading activity in porcine arteries ex vivo [J].
Chesler, NC ;
Ku, DN ;
Galis, ZS .
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 1999, 277 (05) :H2002-H2009
[8]  
Collen D, 2001, Hematology Am Soc Hematol Educ Program, P1
[9]   Metalloproteinase inhibition reduces constrictive arterial remodeling after balloon angioplasty - A study in the atherosclerotic yucatan micropig [J].
de Smet, BJGL ;
de Kleijn, D ;
Hanemaaijer, R ;
Verheijen, JH ;
Robertus, L ;
van der Helm, YJM ;
Borst, C ;
Post, MJ .
CIRCULATION, 2000, 101 (25) :2962-2967
[10]   Increased expression of urokinase during atherosclerotic lesion development causes arterial constriction and lumen loss, and accelerates lesion growth [J].
Falkenberg, M ;
Tom, C ;
DeYoung, MB ;
Wen, S ;
Linnemann, R ;
Dichek, DA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (16) :10665-10670